Optimal Medical Therapy with or without PCI for Stable Coronary Disease
William E. Boden, M.D., Robert A. O'Rourke, M.D., Koon K. Teo, M.B., B.Ch., Ph.D., Pamela M. Hartigan, Ph.D., David J. Maron, M.D., William J. Kostuk, M.D., Merril Knudtson, M.D., Marcin Dada, M.D., Paul Casperson, Ph.D., Crystal L. Harris, Pharm.D., Bernard R. Chaitman, M.D., Leslee Shaw, Ph.D., Gilbert Gosselin, M.D., Shah Nawaz, M.D., Lawrence M. Title, M.D., Gerald Gau, M.D., Alvin S. Blaustein, M.D., David C. Booth, M.D., Eric R. Bates, M.D., John A. Spertus, M.D., M.P.H., Daniel S. Berman, M.D., G.B. John Mancini, M.D., William S. Weintraub, M.D., for the COURAGE Trial Research Group
Background In patients with stable coronary artery disease,it remains unclear whether an initial management strategy ofpercutaneous coronary intervention (PCI) with intensive pharmacologictherapy and lifestyle intervention (optimal medical therapy)is superior to optimal medical therapy alone in reducing therisk of cardiovascular events.
Methods We conducted a randomized trial involving 2287 patientswho had objective evidence of myocardial ischemia and significantcoronary artery disease at 50 U.S. and Canadian centers. Between1999 and 2004, we assigned 1149 patients to undergo PCI withoptimal medical therapy (PCI group) and 1138 to receive optimalmedical therapy alone (medical-therapy group). The primary outcomewas death from any cause and nonfatal myocardial infarctionduring a follow-up period of 2.5 to 7.0 years (median, 4.6).
Results There were 211 primary events in the PCI group and 202events in the medical-therapy group. The 4.6-year cumulativeprimary-event rates were 19.0% in the PCI group and 18.5% inthe medical-therapy group (hazard ratio for the PCI group, 1.05;95% confidence interval [CI], 0.87 to 1.27; P=0.62). There wereno significant differences between the PCI group and the medical-therapygroup in the composite of death, myocardial infarction, andstroke (20.0% vs. 19.5%; hazard ratio, 1.05; 95% CI, 0.87 to1.27; P=0.62); hospitalization for acute coronary syndrome (12.4%vs. 11.8%; hazard ratio, 1.07; 95% CI, 0.84 to 1.37; P=0.56);or myocardial infarction (13.2% vs. 12.3%; hazard ratio, 1.13;95% CI, 0.89 to 1.43; P=0.33).
Conclusions As an initial management strategy in patients withstable coronary artery disease, PCI did not reduce the riskof death, myocardial infarction, or other major cardiovascularevents when added to optimal medical therapy. (ClinicalTrials.govnumber, NCT00007657
[ClinicalTrials.gov]
.)
Source Information
Affiliations for all authors are listed in the Appendix. This article (10.1056/NEJMoa070829) was published at www.nejm.org on March 26, 2007.
Address reprint requests to Dr. Boden at the Division of Cardiology, Buffalo General Hospital, 100 High St., Buffalo, NY 14203, or at wboden{at}kaleidahealth.org.
PCI for Stable Coronary Disease
Katritsis D. G., Ioannidis J. P.A., Wharton T. P. Jr., Umans V. A., Peels H. O., Shah A. P., Shavelle D. M., French W. J., De Servi S., Kiat H., Nagajothi N., Velazquez-Cecena J.-L. E., Khosla S., Mak K.-H., Boden W. E., Teo K. K., Weintraub W. S., the COURAGE Trial Investigators
Extract |
Full Text |
PDF
N Engl J Med 2007;
357:414-418, Jul 26, 2007.
Correspondence
This article has been cited by other articles:
Boden, W. E., Taggart, D. P.
(2009). Diabetes with Coronary Disease -- A Moving Target amid Evolving Therapies?. NEJM
360: 2570-2572
[Full Text]
The BARI 2D Study Group,
(2009). A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease. NEJM
360: 2503-2515
[Abstract][Full Text]
Diamond, G. A., Kaul, S., Boden, W. E.
(2009). A 300-Year-Old Solution to the Health Care Crisis. Arch Intern Med
169: 1019-1021
[Full Text]
Aldea, G. S., Mokadam, N. A., Melford, R. Jr, Stewart, D., Maynard, C., Reisman, M., Goss, R.
(2009). Changing Volumes, Risk Profiles, and Outcomes of Coronary Artery Bypass Grafting and Percutaneous Coronary Interventions.. Ann. Thorac. Surg.
87: 1828-1838
[Abstract][Full Text]
Kurlansky, P.
(2009). Invited Commentary.. Ann. Thorac. Surg.
87: 1838-1838
[Full Text]
Botnar, R. M.
(2009). Coronary Plaque Characterization by T1-Weighted Cardiac Magnetic Resonance. J Am Coll Cardiol Img
2: 729-730
[Full Text]
Pitt, B.
(2009). Angiotensin-converting enzyme inhibitors in patients with vascular disease. Eur Heart J
30: 1307-1309
[Full Text]
Di Mario, C.
(2009). Ars Longa, Vita Brevis. J Am Coll Cardiol Intv
2: 487-488
[Full Text]
Leon, M. B., Allocco, D. J., Dawkins, K. D., Baim, D. S.
(2009). Late Clinical Events After Drug-Eluting Stents: The Interplay Between Stent-Related and Natural History-Driven Events. J Am Coll Cardiol Intv
2: 504-512
[Abstract][Full Text]
Vogel, R. A.
(2009). Drug-Eluting Stents: Safe But Not Sufficient. J Am Coll Cardiol Intv
2: 513-514
[Full Text]
Sarno, G., Decraemer, I., Vanhoenacker, P. K., De Bruyne, B., Hamilos, M., Cuisset, T., Wyffels, E., Bartunek, J., Heyndrickx, G. R., Wijns, W.
(2009). On the Inappropriateness of Noninvasive Multidetector Computed Tomography Coronary Angiography to Trigger Coronary Revascularization: A Comparison With Invasive Angiography. J Am Coll Cardiol Intv
2: 550-557
[Abstract][Full Text]
Turan, T. N., Derdeyn, C. P., Fiorella, D., Chimowitz, M. I.
(2009). Treatment of Atherosclerotic Intracranial Arterial Stenosis. Stroke
40: 2257-2261
[Full Text]
Allison, T. G.
(2009). Improving Weight Loss in Cardiac Rehabilitation. Circulation
119: 2650-2652
[Full Text]
Brar, S. S., Gray, W. A., Nagajothi, N., Arora, R., Khosla, S., Garg, S., Rademaker, T., Serruys, P., Pijls, N. H.J., Tonino, P. A.L., Fearon, W. F., the FAME Investigators,
(2009). Fractional Flow Reserve for Guiding PCI. NEJM
360: 2024-2027
[Full Text]
Dweck, M., Campbell, I. W, Miller, D., Francis, C M.
(2009). Clinical aspects of silent myocardial ischaemia: with particular reference to diabetes mellitus. British Journal of Diabetes & Vascular Disease
9: 110-116
[Abstract]
Subramanian, S., Sabik, J. F. III, Houghtaling, P. L., Nowicki, E. R., Blackstone, E. H., Lytle, B. W.
(2009). Decision-making for patients with patent left internal thoracic artery grafts to left anterior descending.. Ann. Thorac. Surg.
87: 1392-1398
[Abstract][Full Text]
Hendel, R. C.
(2009). Is Computed Tomography Coronary Angiography the Most Accurate and Effective Noninvasive Imaging Tool to Evaluate Patients With Acute Chest Pain in the Emergency Department?: CT Coronary Angiography Is the Most Accurate and Effective Noninvasive Imaging Tool for Evaluating Patients Presenting With Chest Pain to the Emergency Department: Antagonist Viewpoint. Circ Cardiovasc Imaging
2: 264-275
[Full Text]
Bjorck, L., Rosengren, A., Bennett, K., Lappas, G., Capewell, S.
(2009). Modelling the decreasing coronary heart disease mortality in Sweden between 1986 and 2002. Eur Heart J
30: 1046-1056
[Abstract][Full Text]
Hu, G., Oboukhova, E. A., Kumar, S., Sturek, M., Obukhov, A. G.
(2009). Canonical Transient Receptor Potential Channels Expression Is Elevated in a Porcine Model of Metabolic Syndrome. Mol. Endocrinol.
23: 689-699
[Abstract][Full Text]
George, R. T., Arbab-Zadeh, A., Miller, J. M., Kitagawa, K., Chang, H.-J., Bluemke, D. A., Becker, L., Yousuf, O., Texter, J., Lardo, A. C., Lima, J. A.C.
(2009). Adenosine Stress 64- and 256-Row Detector Computed Tomography Angiography and Perfusion Imaging: A Pilot Study Evaluating the Transmural Extent of Perfusion Abnormalities to Predict Atherosclerosis Causing Myocardial Ischemia. Circ Cardiovasc Imaging
2: 174-182
[Abstract][Full Text]
Fox, K. A A
(2009). COURAGE to change practice? Revascularisation in patients with stable coronary artery disease. Heart
95: 689-692
[Full Text]
Wilson, S. R., Scirica, B. M., Braunwald, E., Murphy, S. A., Karwatowska-Prokopczuk, E., Buros, J. L., Chaitman, B. R., Morrow, D. A.
(2009). Efficacy of ranolazine in patients with chronic angina observations from the randomized, double-blind, placebo-controlled MERLIN-TIMI (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Segment Elevation Acute Coronary Syndromes) 36 Trial.. J Am Coll Cardiol
53: 1510-1516
[Abstract][Full Text]
Ting, H. H., Shojania, K. G., Montori, V. M., Bradley, E. H.
(2009). Quality Improvement: Science and Action. Circulation
119: 1962-1974
[Full Text]
Nagel, E.
(2009). Taking the Last Hurdles: Magnetic Resonance Myocardial Perfusion Imaging. J Am Coll Cardiol Img
2: 434-436
[Full Text]
Nissen, S. E.
(2009). The Vulnerable Plaque "Hypothesis": Promise, but Little Progress. J Am Coll Cardiol Img
2: 483-485
[Full Text]
Horst, B., Rihal, C. S., Holmes, D. R. Jr, Bresnahan, J. F., Prasad, A., Gau, G., Lennon, R., Lerman, A.
(2009). Comparison of Drug-Eluting and Bare-Metal Stents for Stable Coronary Artery Disease. J Am Coll Cardiol Intv
2: 321-328
[Abstract][Full Text]
Sanchis, J., Bodi, V., Nunez, J., Mainar, L., Nunez, E., Merlos, P., Rumiz, E., Minana, G., Bosch, X., Llacer, A.
(2009). Efficacy of Coronary Revascularization in Patients With Acute Chest Pain Managed in a Chest Pain Unit. Mayo Clin Proc.
84: 323-329
[Abstract][Full Text]
Thompson, W. G., Gau, G. T.
(2009). Hypertriglyceridemia and Its Pharmacologic Treatment Among US Adults--Invited Commentary. Arch Intern Med
169: 578-579
[Full Text]
Parra, D., Rosenstein, R., Strauss, M. H., Weinstein, J., Newton, G. E., Davis, B. R., Whelton, P. K., the ALLHAT Collaborative Research Group, , Jamerson, K. A., Weber, M. A.
(2009). Benazepril plus Amlodipine or Hydrochlorothiazide for Hypertension. NEJM
360: 1147-1150
[Full Text]
Califf, R. M., Peterson, E. D.
(2009). Public reporting of quality measures what are we trying to accomplish?. J Am Coll Cardiol
53: 831-833
[Full Text]
Chua, T
(2009). The evolving role of molecular imaging for coronary artery disease: where do we stand today?. Heart Asia
2009: 1-5
[Abstract][Full Text]
Krumholz, H. M.
(2009). Questioning Conventional Wisdom. Circ Cardiovasc Qual Outcomes
2: 59-60
[Full Text]
Husmann, L., Herzog, B. A., Gaemperli, O., Tatsugami, F., Burkhard, N., Valenta, I., Veit-Haibach, P., Wyss, C. A., Landmesser, U., Kaufmann, P. A.
(2009). Diagnostic accuracy of computed tomography coronary angiography and evaluation of stress-only single-photon emission computed tomography/computed tomography hybrid imaging: comparison of prospective electrocardiogram-triggering vs. retrospective gating. Eur Heart J
30: 600-607
[Abstract][Full Text]
Tardif, J.-C., Ponikowski, P., Kahan, T., for the ASSOCIATE study Investigators,
(2009). Efficacy of the If current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial. Eur Heart J
30: 540-548
[Abstract][Full Text]
Laukkanen, J. A., Makikallio, T. H., Rauramaa, R., Kurl, S.
(2009). Asymptomatic ST-segment depression during exercise testing and the risk of sudden cardiac death in middle-aged men: a population-based follow-up study. Eur Heart J
30: 558-565
[Abstract][Full Text]
Sajadieh, A.
(2009). A new combination therapy in stable angina pectoris. Eur Heart J
30: 524-525
[Full Text]
Wijeysundera, H. C., Ko, D. T.
(2009). Does Percutaneous Coronary Intervention Reduce Mortality in Patients With Stable Chronic Angina: Are We Talking About Apples and Oranges?. Circ Cardiovasc Qual Outcomes
2: 123-126
[Full Text]
Diamond, G. A., Kaul, S.
(2009). Evidence-Based Financial Incentives for Healthcare Reform: Putting It Together. Circ Cardiovasc Qual Outcomes
2: 134-140
[Full Text]
Stirrup, J., Wechalekar, K., Maenhout, A., Anagnostopoulos, C.
(2009). Cardiac radionuclide imaging in stable coronary artery disease and acute coronary syndromes. Br Med Bull
89: 63-78
[Abstract][Full Text]
Hemingway, H.
(2009). States, rates and traits: prognosis research and chronic stable angina. Heart
95: 439-440
[Full Text]
Tricoci, P., Allen, J. M., Kramer, J. M., Califf, R. M., Smith, S. C. Jr
(2009). Scientific Evidence Underlying the ACC/AHA Clinical Practice Guidelines. JAMA
301: 831-841
[Abstract][Full Text]
Venkitachalam, L., Kip, K. E., Selzer, F., Wilensky, R. L., Slater, J., Mulukutla, S. R., Marroquin, O. C., Block, P. C., Williams, D. O., Kelsey, S. F., for the Investigators of NHLBI-Sponsored 1985-1986,
(2009). Twenty-Year Evolution of Percutaneous Coronary Intervention and Its Impact on Clinical Outcomes: A Report From the National Heart, Lung, and Blood Institute-Sponsored, Multicenter 1985-1986 PTCA and 1997-2006 Dynamic Registries. Circ Cardiovasc Intervent
2: 6-13
[Abstract][Full Text]
Neglia, D., L'Abbate, A.
(2009). Myocardial Perfusion Reserve in Ischemic Heart Disease. JNM
50: 175-177
[Full Text]
Tonino, P. A.L., De Bruyne, B., Pijls, N. H.J., Siebert, U., Ikeno, F., van `t Veer, M., Klauss, V., Manoharan, G., Engstrom, T., Oldroyd, K. G., Ver Lee, P. N., MacCarthy, P. A., Fearon, W. F., the FAME Study Investigators,
(2009). Fractional Flow Reserve versus Angiography for Guiding Percutaneous Coronary Intervention. NEJM
360: 213-224
[Abstract][Full Text]
Ellis, S. G.
(2009). Refining the Art and Science of Coronary Stenting. NEJM
360: 292-294
[Full Text]
de Belder, M. A, Hamilton, L.
(2009). Evaluating risks and benefits in coronary revascularisation--a very imperfect art?. Heart
95: 6-8
[Full Text]
Kinnaird, T, Anderson, R, Hill, J, Thomas, M
(2009). Bleeding during percutaneous intervention: tailoring the approach to minimise risk. Heart
95: 15-19
[Abstract][Full Text]
Bodi, V, Sanchis, J, Lopez-Lereu, M P, Nunez, J, Mainar, L, Monmeneu, J V, Ruiz, V, Rumiz, E, Husser, O, Moratal, D, Millet, J, Chorro, F J, Llacer, A
(2009). Prognostic and therapeutic implications of dipyridamole stress cardiovascular magnetic resonance on the basis of the ischaemic cascade. Heart
95: 49-55
[Abstract][Full Text]
American Diabetes Association,
(2009). Standards of Medical Care in Diabetes--2009. Diabetes Care
32: S13-S61
[Full Text]
Joshi, S. B.
(2008). Letter by Joshi Regarding Article, "Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden: Results From the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy". Circulation
118: e838-e838
[Full Text]
Lucas, F.L., Siewers, A.E., Malenka, D.J., Wennberg, D.E.
(2008). Diagnostic-Therapeutic Cascade Revisited: Coronary Angiography, Coronary Artery Bypass Graft Surgery, and Percutaneous Coronary Intervention in the Modern Era. Circulation
118: 2797-2802
[Abstract][Full Text]
Piers, L. H., Dikkers, R., Willems, T. P., de Smet, B. J.G.L., Oudkerk, M., Zijlstra, F., Tio, R. A.
(2008). Computed tomographic angiography or conventional coronary angiography in therapeutic decision-making. Eur Heart J
29: 2902-2907
[Abstract][Full Text]
Miller, J. M., Rochitte, C. E., Dewey, M., Arbab-Zadeh, A., Niinuma, H., Gottlieb, I., Paul, N., Clouse, M. E., Shapiro, E. P., Hoe, J., Lardo, A. C., Bush, D. E., de Roos, A., Cox, C., Brinker, J., Lima, J. A.C.
(2008). Diagnostic Performance of Coronary Angiography by 64-Row CT. NEJM
359: 2324-2336
[Abstract][Full Text]
Beltrame, J. F., Tavella, R., Cutri, N., Rodriguez, A. E., Maree, A. O., Palacios, I. F., Reppel, M., Radke, P. W., Schunkert, H., Kinlay, S., Brown, R. A., Teirstein, P. S., Kandzari, D. E., Smith, J., Weintraub, W. S., Kolm, P., Boden, W. E., Peterson, E. D., Rumsfeld, J. S.
(2008). Quality of Life with PCI versus Medical Therapy in Stable Coronary Disease. NEJM
359: 2289-2293
[Full Text]
Gibbons, R. J.
(2008). Noninvasive Diagnosis and Prognosis Assessment in Chronic Coronary Artery Disease: Stress Testing With and Without Imaging Perspective. Circ Cardiovasc Imaging
1: 257-269
[Full Text]
Lin, G. A., Dudley, R. A., Lucas, F. L., Malenka, D. J., Vittinghoff, E., Redberg, R. F.
(2008). Frequency of Stress Testing to Document Ischemia Prior to Elective Percutaneous Coronary Intervention. JAMA
300: 1765-1773
[Abstract][Full Text]
Diamond, G. A., Kaul, S.
(2008). The Disconnect Between Practice Guidelines and Clinical Practice--Stressed Out. JAMA
300: 1817-1819
[Full Text]
Nishigaki, K., Yamazaki, T., Kitabatake, A., Yamaguchi, T., Kanmatsuse, K., Kodama, I., Takekoshi, N., Tomoike, H., Hori, M., Matsuzaki, M., Takeshita, A., Shimbo, T., Fujiwara, H., for the JSAP (Japanese Stable Angina Pectoris) Stu,
(2008). Percutaneous Coronary Intervention Plus Medical Therapy Reduces the Incidence of Acute Coronary Syndrome More Effectively Than Initial Medical Therapy Only Among Patients With Low-Risk Coronary Artery Disease: A Randomized, Comparative, Multicenter Study. J Am Coll Cardiol Intv
1: 469-479
[Abstract][Full Text]
Gerber, T. C., Asirvatham, S. J., Lavie, C. J., Oh, J. K.
(2008). Introduction to Symposium on Cardiovascular Diseases. Mayo Clin Proc.
83: 1168-1169
[Full Text]
Mauri, L., Silbaugh, T. S., Garg, P., Wolf, R. E., Zelevinsky, K., Lovett, A., Varma, M. R., Zhou, Z., Normand, S.-L. T.
(2008). Drug-Eluting or Bare-Metal Stents for Acute Myocardial Infarction. NEJM
359: 1330-1342
[Abstract][Full Text]
Fowler, M. B.
(2008). Hypertension, Heart Failure, and Beta-Adrenergic Blocking Drugs. J Am Coll Cardiol
52: 1073-1075
[Full Text]
Nallamothu, B. K., Hayward, R. A., Bates, E. R.
(2008). Beyond the Randomized Clinical Trial: The Role of Effectiveness Studies in Evaluating Cardiovascular Therapies. Circulation
118: 1294-1303
[Full Text]
Katritsis, D. G., Meier, B.
(2008). Percutaneous Coronary Intervention for Stable Coronary Artery Disease. J Am Coll Cardiol
52: 889-893
[Abstract][Full Text]
Schomig, A., Mehilli, J., de Waha, A., Seyfarth, M., Pache, J., Kastrati, A.
(2008). A Meta-Analysis of 17 Randomized Trials of a Percutaneous Coronary Intervention-Based Strategy in Patients With Stable Coronary Artery Disease. J Am Coll Cardiol
52: 894-904
[Abstract][Full Text]
O'Rourke, R. A.
(2008). Optimal Medical Therapy Is a Proven Option for Chronic Stable Angina. J Am Coll Cardiol
52: 905-907
[Abstract][Full Text]
Kirtane, A. J., Cohen, D. J.
(2008). When Is Better Not Good Enough?: Insights From the COURAGE Economic Study. Circ Cardiovasc Qual Outcomes
1: 4-6
[Full Text]
Athappan, G., Subramanian, T.
(2008). Medical, angioplasty or surgery for stable coronary artery disease; do we have an answer !!!. Eur. J. Cardiothorac. Surg.
34: 702-703
[Full Text]
Weintraub, W. S., Boden, W. E., Zhang, Z., Kolm, P., Zhang, Z., Spertus, J. A., Hartigan, P., Veledar, E., Jurkovitz, C., Bowen, J., Maron, D. J., O'Rourke, R., Dada, M., Teo, K. K., Goeree, R., Barnett, P. G., on Behalf of the Department of Veterans Affairs Co,
(2008). Cost-Effectiveness of Percutaneous Coronary Intervention in Optimally Treated Stable Coronary Patients. Circ Cardiovasc Qual Outcomes
1: 12-20
[Abstract][Full Text]
Gardner, C. M., Tan, H., Hull, E. L., Lisauskas, J. B., Sum, S. T., Meese, T. M., Jiang, C., Madden, S. P., Caplan, J. D., Burke, A. P., Virmani, R., Goldstein, J., Muller, J. E.
(2008). Detection of lipid core coronary plaques in autopsy specimens with a novel catheter-based near-infrared spectroscopy system.. J Am Coll Cardiol Img
1: 638-648
[Abstract][Full Text]
Fricke, E., Eckert, S., Dongas, A., Fricke, H., Preuss, R., Lindner, O., Horstkotte, D., Burchert, W.
(2008). Myocardial Sympathetic Innervation in Patients with Symptomatic Coronary Artery Disease: Follow-up After 1 Year with Neurostimulation. JNM
49: 1458-1464
[Abstract][Full Text]
(2008). Current Guidelines for Preoperative Management Leave Me Wanting More. Journal Watch Hospital Medicine
2008: 1-1
[Full Text]
Hemingway, H., Chen, R., Junghans, C., Timmis, A., Eldridge, S., Black, N., Shekelle, P., Feder, G.
(2008). Appropriateness Criteria for Coronary Angiography in Angina: Reliability and Validity. ANN INTERN MED
149: 221-231
[Abstract][Full Text]
Faxon, D. P.
(2008). Assessing Appropriateness of Coronary Angiography: Another Step in Improving Quality. ANN INTERN MED
149: 276-278
[Full Text]
Weintraub, W. S., Spertus, J. A., Kolm, P., Maron, D. J., Zhang, Z., Jurkovitz, C., Zhang, W., Hartigan, P. M., Lewis, C., Veledar, E., Bowen, J., Dunbar, S. B., Deaton, C., Kaufman, S., O'Rourke, R. A., Goeree, R., Barnett, P. G., Teo, K. K., Boden, W. E., the COURAGE Trial Research Group,
(2008). Effect of PCI on Quality of Life in Patients with Stable Coronary Disease. NEJM
359: 677-687
[Abstract][Full Text]
Peterson, E. D., Rumsfeld, J. S.
(2008). Finding the Courage to Reconsider Medical Therapy for Stable Angina. NEJM
359: 751-753
[Full Text]
Singh, M., Peterson, E. D., Milford-Beland, S., Rumsfeld, J. S., Spertus, J. A.
(2008). Validation of the Mayo Clinic Risk Score for In-Hospital Mortality After Percutaneous Coronary Interventions Using the National Cardiovascular Data Registry. Circ Cardiovasc Intervent
1: 36-44
[Abstract][Full Text]
Holmes, D. R. Jr, Williams, D. O.
(2008). Catheter-Based Treatment of Coronary Artery Disease: Past, Present, and Future. Circ Cardiovasc Intervent
1: 60-73
[Abstract][Full Text]
Krumholz, H. M.
(2008). Outcomes Research: Generating Evidence for Best Practice and Policies. Circulation
118: 309-318
[Full Text]
Gehi, A. K., Ali, S., Na, B., Schiller, N. B., Whooley, M. A.
(2008). Inducible Ischemia and the Risk of Recurrent Cardiovascular Events in Outpatients With Stable Coronary Heart Disease: The Heart and Soul Study. Arch Intern Med
168: 1423-1428
[Abstract][Full Text]
Ferri, N., Granata, A., Pirola, C., Torti, F., Pfister, P. J., Dorent, R., Corsini, A.
(2008). Fluvastatin Synergistically Improves the Antiproliferative Effect of Everolimus on Rat Smooth Muscle Cells by Altering p27Kip1/Cyclin E Expression. Mol. Pharmacol.
74: 144-153
[Abstract][Full Text]
Lentine, K. L., Schnitzler, M. A., Brennan, D. C., Snyder, J. J., Hauptman, P. J., Abbott, K. C., Axelrod, D., Salvalaggio, P. R., Kasiske, B.
(2008). Cardiac Evaluation before Kidney Transplantation: A Practice Patterns Analysis in Medicare-insured Dialysis Patients. CJASN
3: 1115-1124
[Abstract][Full Text]
Coylewright, M., Blumenthal, R. S., Post, W.
(2008). Placing COURAGE in Context: Review of the Recent Literature on Managing Stable Coronary Artery Disease. Mayo Clin Proc.
83: 799-805
[Abstract][Full Text]
Dixon, S. R., Grines, C. L., O'Neill, W. W.
(2008). The year in interventional cardiology.. J Am Coll Cardiol
51: 2355-2369
[Full Text]
Brett, A. S.
(2008). Coronary Assessment Before Noncardiac Surgery: Current Strategies Are Flawed. Circulation
117: 3145-3151
[Full Text]
Bloomgarden, Z. T.
(2008). Cardiovascular Disease in Diabetes. Diabetes Care
31: 1260-1266
[Full Text]
Saito, M, Okayama, H, Nishimura, K, Ogimoto, A, Ohtsuka, T, Inoue, K, Hiasa, G, Sumimoto, T, Higaki, J
(2008). Possible link between large artery stiffness and coronary flow velocity reserve. Heart
94: e20-e20
[Abstract][Full Text]